Cable Hill Partners’s Juno Therapeutics, Inc. JUNO Stock Holding History
Bought
Maintained
Sold
Other funds holding JUNO
Cable Hill Partners's JUNO Position: Q1 2018 in Review
Cable Hill Partners sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 500 shares — an estimated $24K sold.
Cable Hill Partners first reported a position in JUNO in Q3 2017 and held it in 2 quarters. The position peaked at $24K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.
- Cable Hill Partners reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
- Cable Hill Partners sold 500 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $24K.
- Cable Hill Partners first reported a position in Juno Therapeutics, Inc. in Q3 2017 and held it in 2 quarters.
- Cable Hill Partners's Juno Therapeutics, Inc. position peaked at $24K in Q4 2017.
- 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.
Based on Cable Hill Partners's 13F filing for Q1 2018, filed 20 Apr 2018.